Search 33,000+ CME courses
Back

StatPearls, LLC

  • Diabetes Mellitus, Type 2
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Hypoglycemia
  • Hypoglycemic Agents
  • Metformin

Oral Antidiabetic Medications

Oral antidiabetic medications play a central role in the management of type 2 diabetes, particularly as progressive pancreatic beta-cell dysfunction necessitates ongoing pharmacologic intensification. Recent therapeutic advances, including sodium-glucose cotransporter 2 inhibitors and oral glucagon-like peptide-1 receptor agonists, have expanded treatment options beyond glycemic control to include cardiovascular and renal risk reduction. This activity reviews the pharmacology, indications, dosing strategies, adverse effects, contraindications, monitoring considerations, and toxicology of major classes of oral antidiabetic medications, including metformin, sulfonylureas, sodium-glucose cotransporter 2 inhibitors, and oral glucagon-like peptide-1 receptor agonists. Participants will enhance their ability to individualize therapy based on comorbidities, renal function, hypoglycemia risk, and other patient-specific factors while applying current guideline-directed recommendations. The activity also emphasizes interprofessional collaboration to improve medication safety, adherence, cardiometabolic outcomes, and long-term management of patients with type 2 diabetes and associated chronic complications.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABOS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 10 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

Related courses

See all

Other providers’ courses on the same topic

More from StatPearls, LLC

See all

This provider’s courses closest to this one